We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$929M
AUM Growth
+$86.9M
Cap. Flow
+$794K
Cap. Flow %
0.09%
Top 10 Hldgs %
37.66%
Holding
156
New
14
Increased
50
Reduced
52
Closed
10

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$4.87M
2
AAPL icon
Apple
AAPL
+$4.37M
3
BMY icon
Bristol-Myers Squibb
BMY
+$3.93M
4
PRGO icon
Perrigo
PRGO
+$2.46M
5
MDT icon
Medtronic
MDT
+$2.06M

Sector Composition

Rank Sector Weight
1 Technology 25.85%
2 Healthcare 15.19%
3 Financials 14.38%
4 Consumer Discretionary 12.37%
5 Communication Services 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTGX icon
101
Protagonist Therapeutics
PTGX
$8.83B
$435K 0.05%
22,250
-1,050
-5% -$19.7K
NKTR icon
102
Nektar Therapeutics
NKTR
$2.47B
$423K 0.05%
1,700
-167
-9% -$52.5K
DOW icon
103
Dow Inc
DOW
$21.4B
$421K 0.05%
8,946
+200
+2% +$8.98K
KYNB
104
Kyntra Bio
KYNB
$28.3M
$411K 0.04%
400
CALA
105
DELISTED
Calithera Biosciences, Inc
CALA
$388K 0.04%
5,629
ABT icon
106
Abbott
ABT
$183B
$382K 0.04%
3,511
+670
+24% +$68K
SMG icon
107
ScottsMiracle-Gro
SMG
$3.85B
$373K 0.04%
2,440
+190
+8% +$29.4K
STZ icon
108
Constellation Brands
STZ
$22.3B
$352K 0.04%
1,855
-270
-13% -$49.2K
DD icon
109
DuPont de Nemours
DD
$19.9B
$338K 0.04%
4,848
BX icon
110
Blackstone
BX
$109B
$313K 0.03%
+6,000
New +$321K
TFC icon
111
Truist Financial
TFC
$64.6B
$307K 0.03%
8,074
-1,103
-12% -$41.6K
COF icon
112
Capital One
COF
$136B
$299K 0.03%
4,154
+154
+4% +$10.3K
SBR
113
Sabine Royalty Trust
SBR
$1.03B
$293K 0.03%
10,081
BAC icon
114
Bank of America
BAC
$442B
$289K 0.03%
12,004
-4,380
-27% -$109K
PRQR icon
115
ProQR Therapeutics
PRQR
$278M
$287K 0.03%
60,000
GS icon
116
Goldman Sachs
GS
$313B
$286K 0.03%
+1,425
New +$290K
FDX icon
117
FedEx
FDX
$73.5B
$277K 0.03%
+1,103
New +$221K
MAS icon
118
Masco
MAS
$15.2B
$273K 0.03%
4,950
PRGO icon
119
Perrigo
PRGO
$1.84B
$265K 0.03%
5,779
-46,972
-89% -$2.46M
UL icon
120
Unilever
UL
$139B
$262K 0.03%
+3,773
New +$252K
A icon
121
Agilent Technologies
A
$39.9B
$260K 0.03%
2,575
BCRX icon
122
BioCryst Pharmaceuticals
BCRX
$2.31B
$258K 0.03%
75,000
KMB icon
123
Kimberly-Clark
KMB
$37.3B
$249K 0.03%
1,689
+14
+0.8% +$2.1K
DGX icon
124
Quest Diagnostics
DGX
$26B
$245K 0.03%
2,143
+36
+2% +$4.25K
FPRX
125
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$235K 0.03%
50,000

Similar funds

Franklin Street Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Franklin Street Advisors held 156 positions worth $929M, up 10% from $842M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Franklin Street Advisors's Q3 2020 filing shows 14 new, 50 increased, 52 reduced and 10 closed positions. Its largest new stake was Paramount Global Class B: 201,983 shares worth $5.66M. The largest sale was AT&T, an estimated $4.87M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Franklin Street Advisors's largest Q3 2020 buy was Paramount Global Class B: 201,983 shares worth $5.66M.
  • Franklin Street Advisors added most to Pfizer in Q3 2020, an estimated $6.62M increase.
  • Franklin Street Advisors's biggest Q3 2020 reduction was AT&T, cutting an estimated $4.87M.
  • Franklin Street Advisors fully exited Repligen in Q3 2020, selling an estimated $1.24M.
  • Franklin Street Advisors's ten largest holdings make up 38% of its $929M portfolio in Q3 2020.
  • Franklin Street Advisors opened 14 new positions and closed 10 in Q3 2020.
  • Franklin Street Advisors's portfolio value rose 10% quarter-over-quarter to $929M.

Based on Franklin Street Advisors's 13F filing for Q3 2020, filed 21 Oct 2020.